Role of the basic helix-loop-helix transcription factor p48 in the differentiation phenotype of exocrine pancreas cancer cells

Cell Growth and Differentiation

Volumn 11, Issue 3, 2000, Pages 137-147

  Adell, Teresa ^a   Gómez Cuadrado, Alicia ^a   Skoudy, Anouchka ^a   Pettengill, Olive S ^b   Longnecker, Daniel S ^b   Real, Francisco X ^a,c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; AZASERINE; COMPLEMENTARY DNA; HELIX LOOP HELIX PROTEIN; PANCREATIC ELASTASE; TRANSCRIPTION FACTOR P48; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PANCREAS ADENOCARCINOMA; PHENOTYPE; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZASERINE; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; HELIX-LOOP-HELIX MOTIFS; HUMANS; MOLECULAR SEQUENCE DATA; PANCREAS; PANCREATIC NEOPLASMS; PHENOTYPE; RATS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0342369386     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Klöppel, G. Pathology of nonendocrine pancreatic tumors. In: V. L. W. Go, E. P. DiMagno, J. D. Gardner, E. Lebenthal, H. A. Reber, and G. A. Scheele (ed.). The Pancreas: Biology, Pathobiology, and Disease, pp. 871-898. New York: Raven Press, 1993.
2. Real, F. X. The cell biology of pancreatic cancer. In: J. Neoptolemos and N. R. Lemoine (eds), Pancreatic Cancer, pp. 3-17. Oxford: Blackwell Science Press, 1995.
3. Schüssler, M. H., Skoudy, A., Ramaekers, F., and Real, F. X. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am. J. Pathol., 140: 559-568, 1992.
4. Real, F. X., Vilá, M. R., Skoudy, A., Ramaekers, F. C. S., and Corominas, J. M. Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer. Int. J. Cancer, 54: 720-727, 1993.
5. Vilá, M. R., Balagué, C., and Real, F. X. Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. Zentralbl. Pathol, 140: 225-235, 1994.
6. Balagué, C., Gambús, G., Carrato, C., Porchet, N., Aubert, J. P., Kim, Y. S., and Real, F. X. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology, 106: 1054-1061, 1994.
7. Balagué, C., Audié, J. P., Porchet, N., and Real, F. X. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology, 109: 953-964, 1995.
8. Hartel, S., Gossrau, R., Hanski, C., and Reutter, W. Dipeptidyl peptidase (DPP) IV in rat organs. Histochemistry, 89: 151-161, 1988.
9. Marino, C. R., Matovcik, L. M., Gorelick, F. S., and Cohn, J. A. Localization of the cystic fibrosis transmembrane conductance regulator in pancreas. J. Clin. Investig., 88: 712-716, 1988.
10. Kim, J. H., Ho, S. B., Montgomery, C. K., and Kim, Y. S. Cell lineage markers in human pancreatic cancer. Cancer (Phila.), 66: 2134-2143, 1990.
11. Vilá, M. R., Lloreta, J., Schüssler, M. H., Berrozpe, G., Welt, S., and Real, F. X. New pancreas cancer cell lines that represent distinct stages of ductal differentiation. Lab. Investig., 72: 395-404, 1995.
12. Scarpelli, D. M., Rao, M. S., and Reddy, J. K. Are acinar cells involved in the pathogenesis of ductal adenocarcinoma of the pancreas? Cancer Cells, 3: 275-277, 1991.
13. Pour, P. M. The role of Langerhans islets in pancreatic ductal adenocarcinomas. Front. Biosci., 2: D271-D282, 1997.
14. Longnecker, D. S., Shinozuka, H., and Dekker, A. Focal acinar cell dysplasia in human pancreas. Cancer (Phila.), 45: 534-540, 1980.
15. Klöppel, G., and Longnecker, D. S. Hyperplastic and metaplastic changes in pancreatic ducts: nomenclature and preneoplastic potential. Ann. NY Acad. Sci., 880: 66-73, 1999.
16. Yanagisawa, A., Ohtake, K., Ohashi, K., Hori, M., Kitagawa, T., Sugano, H., and Kato, Y. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res., 53: 953-956, 1993.
17. Caldas, C., and Kern, S. E. K-ras mutation and pancreatic adenocarcinoma. Int. J. Pancreatol., 18: 1-6, 1995.
18. Luttges, J., Schlehe, B., Menke, M. A., Vogel, I., Henne-Bruns, D., and Klöppel, G. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Cancer (Phila.), 85: 1703-1710, 1999.
19. Caldas, C., Hahn, S. A., Hruban, R. H., Redson, M. S., Yeo, C. J., and Kern, S. E. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res., 54: 3568-3573, 1994.
20. Malats, N. Prevalença i factors associats a les mutacions en 'oncogen Ki-ras en el cáncer de pancrees exocrí i els cáncers del sistema biliar extrahepátic (Estudi PANK-ras I). Doctoral Thesis, Facultat de Medicina, Universitat Autònoma de Barcelona, Barcelona (Spain), 1995.
21. Moskaluk, C. A., Hruban, R. H., and Kern, S. E. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. Cancer Res., 57: 2140-2143, 1997.
22. Erill, N., Cuatrecasas, M., Sancho, F. J., Farre, A., Pour, P. M., Liuis, F., and Capella, G. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Am. J. Pathol., 149: 1333-1339, 1996.
23. Schaeffer, B. K., Zurlo, J., and Longnecker, D. S. Activation of c-Ki-ras not detectable in adenomas or adenocarcinomas arising in rat pancreas. Mol. Carcinog., 3: 165-170, 1990.
24. Jessop, N. W., and Hay, R. J. Characteristics of two rat pancreatic exocrine cell lines derived from transplantable tumors. In Vitro, 16: 212, 1980.
25. Christophe, J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am. J. Physiol., 266: G963-G971, 1994.
26. Pettengill, O. S., Faris, R. A., Bell, R. H., Jr., Kuhlmann, E. T., and Longnecker, D. S. Derivation of ductlike cell lines from transplantable acinar cell carcinoma of the rat pancreas. Am. J. Pathol., 143: 292-303, 1993.
27. Sandgren, E. P., Quaife, C. J., Paulovich, A. G., Palmiter, R. D., and Brinster, R. L. Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc. Natl. Acad. Sci. USA, 88: 93-97, 1991.
28. Cockell, M., Stevenson, B. J., Strubin, O., Hagenbüchle, O., and Wellauer, P. K. Identification of a cell-specific DNA-binding activity that interacts with a transcriptional activator of genes expressed in the acinar pancreas. Mol. Cell. Biol., 9: 2464-2476, 1989.
29. Petrucco, S., Wellauer, P. K., and Hagenbüchle, O. The DNA-binding activity of transcription factor PTF1 parallels the synthesis of pancreas-specific mRNAs during mouse development. Mol. Cell. Biol., 10: 254-264, 1990.
30. Roux, E., Strubin, M., Hagenbüchle, O., and Wellauer, P. K. The cell-specific transcription factor PTF1 contains two different subunits that interact with the DNA. Genes Dev., 3: 1613-1624, 1989.
31. Krapp, A., Knöfler, M., Frutiger, S., Hughes, G. J., Hagenbüchle, O., and Wellauer, P. K. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein. EMBO J., 15: 4317-4329, 1996.
32. Hagenbüchle, O., Krapp, A., Knöfler, M., and Wellauer, P. K. The bHLH protein p48, a DNA-binding subunit of PTF1, acts as a morphogen during pancreas development. Exp. Clin. Endocrinol. Diabetes, 105: 4, 1997.
33. Sommer, L., Hagenbüchle, O., Wellauer, P. K., and Strubin, M. Nuclear targeting of the transcription factor PTF1 is mediated by a protein subunit that does not bind to the PTF1 cognate sequence. Cell, 67: 987-994, 1991.
34. Walsh, K., and Perlman, H. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev., 7: 597-602, 1997.
35. Cockell, M., Stolarczyk, D., Frutiger, S., Hughes, G. J., Hagenbüchle, O., and Wellauer, P. K. Binding sites for hepatocyte nuclear factor 3β or 3γ and pancreas transcription factor 1 are required for efficient expression of the gene encoding pancreatic α-amylase. Mol. Cell. Biol., 15: 1933-1941, 1995.
36. Swift, G. H., Liu, Y., Rose, S. D., Bischof, L. J., Steelman, S., Buchberg, A. M., Wright, C. V., and MacDonald, R. J. An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein PDX1 through formation of a trimeric complex with PBX1b and MRG1 (MEIS2). Mol. Cell. Biol., 18: 5109-5120, 1998.
37. Rose, S. D., Kruse, F., Swift, G. H., MacDonald, R. J., Hammer, R. E. A single element of the elastase I enhancer is sufficient to direct transcription selectively to the pancreas and gut. Mol. Cell. Biol., 14: 2048-2057, 1994.
38. Krapp, A., Knöfler, M., Ledermann, B., Bürki, K., Berney, C., Zoerkler, N., Hagenbüchle, O., and Wellauer, P. K. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev., 12: 3752-3763, 1998.
39. Knöfler, M., Krapp, A., Hagenbüchle, O., and Wellauer, P. K. Constitutive expression of the gene for the cell-specific p48 DNA-binding subunit of pancreas transcription factor 1 in cultured cells is under control of binding sites for transcription factors Sp1 and αCbf. J. Biol. Chem., 271: 21993-22002, 1996.
40. Vilá, M. R., Lloreta, J., and Real, F. X. Normal human pancreas cultures display functional ductal characteristics. Lab. Investig., 71: 423-431, 1994.
41. Adell, T., Skoudy, A., Gomez-Cuadrado, A., Palomero, T., and Real, F. X. The bHLH transcription factor p48 in exocrine pancreas differentiation in vitro. In: T. M. Gress (ed.), Molecular Pathogenesis of Pancreatic Cancer, in press. Amsterdam: IOS Press, 2000.
42. Duluc, I., Freund, J. N., Leberquier, C., and Kédinger, M. Fetal endoderm primarily holds the temporal and positional information required for mammalian intestinal development. J. Cell. Biol., 126: 211-221, 1994.
43. Ahlgren, U., Pfaff, S. L., Jessell, T. M., Edlund, T., and Edlund, H. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature (Lond.), 385: 257-260, 1997.
44. Benezra, R., Davis, R. L., Lockson, D., Turner, D. L., and Weintraub, H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell, 61: 49-59, 1990.
45. Sun, X-H. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell, 79: 893-900, 1994.
46. Norton, J. D., Deed, R. W., Craggs, G., and Sablitzky, F. Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol., 8: 58-65, 1998.
47. Desprez, P-Y., Hara, E., Bissell, M. J., and Campisi, J. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein, Id-1. Mol. Cell. Biol., 15: 3398-3404, 1995.
48. Puri, P. L., Sartorelli, V., Yang, X. J., Hamamori, Y., Ogryzko, W., Howard, B. H., Kedes, L., Wang, J. Y., Graessmann, A., Nakatani, Y., and Levrero, M. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell, 1: 35-45, 1997.
49. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
50. Skapek, S. X., Rhee, J., Spicer, D. B., and Lassar, A. B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (Washington DC), 267: 1022-1024, 1995.
51. Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
52. Otten, A. D., Firpo, E. J., Gerber, A. B., Brody, L. L., Roberts, J. M., and Tapscott, S. J. Inactivalion of MyoD-mediated expression of p21 in tumor cell lines. Cell Growth Differ., 8: 1151-1160, 1997.
53. Frascella, E., and Rosolen, A. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction. Am. J. Pathol., 152: 577-583, 1998.
54. Cui, S., Hano, H., Harada, T., Takai, S., Masui, F., and Ushigome, S. Evaluation of new monoclonal anti-MyoD1 and anti-myogenin antibodies for the diagnosis of rhabdomyosarcoma. Pathol. Int., 49: 62-68, 1999.
55. Novitch, B. G., Spicer, D. B., Kim, P. S., Cheung, W. L., and Lassar, A. B. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol., 9: 449-459, 1999.
56. Chomczynski, P., and Sacchi, N. Single-step method for RNA isolation using guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.